正念减压治疗对心身症状障碍患者的疗效研究  

Effect of mindfulness-based stress reduction on psychosomatic disorder

作　　者：樊欣娜[1] 张晶[1] 陈金良 刘淑华[1] FAN Xinna;ZHANG Jing;CHEN Jinliang;LIU Shuhua(The First Hospital of Qinhuangdao,Qinhuangdao 066000, China;Beidaihe Recuperation Center of People's Liberation Army,Qinhuangdao 066000, China)

机构地区：[1]秦皇岛市第一医院,河北秦皇岛066000 [2]解放军北戴河康复疗养中心,河北秦皇岛066000

出　　处：《东南大学学报（医学版）》2020年第5期629-633,共5页Journal of Southeast University(Medical Science Edition)

基　　金：国家自然科学基金资助项目(30871086);秦皇岛市科技计划项目(201602A239)。

摘　　要：目的:评估正念减压治疗(MBSR)对心身症状障碍(PSD)的疗效。方法:采用随机数字表法将64例PSD患者分为正念减压治疗组(MBSR组)和对照组各32例;两组均给予氟哌噻吨美利曲辛为基础治疗,MBSR组在常规治疗的基础上给予MBSR;于治疗前和治疗8周后对所有患者进行心身症状量表(PSSS)、焦虑自评量表(SAS)、抑郁自评量表(SDS)和正念注意觉知量表(MAAS)进行评估。结果:治疗8周后两组患者PSSS、SAS、SDS、MAAS评分较治疗前均明显降低;治疗前后PSSS、SAS、MAAS差值比较,MBSR组优于对照组。结论:MBSR能有效改善PSD患者的心身症状,这可能与MBSR提高患者正念觉知水平有关。Objective:To evaluate the effect of mindfulness-based stress reduction(MBSR)on psychosomatic disorder(PSD).Methods:A total of 64 PSD patients were randomly divided into the MBSR group(32 cases)and the control group(32 cases).The MBSR group was given MBSR therapy by physicians.Meanwhile,both groups were treated by flupentixol-melitracen for 8 weeks.At the baseline and 8 weeks after the treatment,the patients were assessed using the Psychosomatic Symptom Scale(PSSS),Zung Self-Rating Anxiety Scale(SAS),Zung Self-Rating Depression Scale(SDS)and Mindful Attention Awareness Scale(MAAS).Results:8 weeks after the treatment,the scores of PSSS,SAS,SDS and MAAS were significantly decreased contrast to baseline in both groups,and remarkable change of PSSS,SAS and MAAS was found in the MBSR group than that in the control group.Conclusion:MBSR by physicians can effectively improve PSD symptom and anxiety,it's related to MAAS improvement.

关 键 词：正念减压 心身症状障碍 疗效 

分 类 号：R749.92[医药卫生—神经病学与精神病学] R749.055[医药卫生—临床医学]